{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T18:31:39Z","timestamp":1790015499198,"version":"4.0.1"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2024,9,18]],"date-time":"2024-09-18T00:00:00Z","timestamp":1726617600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,9,18]],"date-time":"2024-09-18T00:00:00Z","timestamp":1726617600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"JSPS KAKENHI","award":["22K08518"],"award-info":[{"award-number":["22K08518"]}]},{"name":"Research Funding of Longevity Sciences","award":["22-10"],"award-info":[{"award-number":["22-10"]}]},{"DOI":"10.13039\/100020237","name":"Japan Health Research Promotion Bureau","doi-asserted-by":"publisher","award":["2022-young researcher-10"],"award-info":[{"award-number":["2022-young researcher-10"]}],"id":[{"id":"10.13039\/100020237","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Hematol"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1007\/s12185-024-03849-2","type":"journal-article","created":{"date-parts":[[2024,9,19]],"date-time":"2024-09-19T19:35:34Z","timestamp":1726774534000},"page":"743-749","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Newly diagnosed multiple myeloma with bleeding and coagulation abnormalities caused by a thrombin-inhibiting substance"],"prefix":"10.1007","volume":"120","author":[{"given":"Fumiya","family":"Ohara","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atsuo","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nobuaki","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takeshi","family":"Kanematsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuichi","family":"Okamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shogo","family":"Tamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hitoshi","family":"Kiyoi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tadashi","family":"Matsushita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2411-0522","authenticated-orcid":false,"given":"Akira","family":"Katsumi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,9,18]]},"reference":[{"key":"3849_CR1","first-page":"29","volume":"50","author":"RA Kyle","year":"1975","unstructured":"Kyle RA. Multiple myeloma: review of 869 cases. Mayo Clin Proc. 1975;50:29\u201340.","journal-title":"Mayo Clin Proc"},{"key":"3849_CR2","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1007\/s12185-009-0363-9","volume":"90","author":"I Sari","year":"2009","unstructured":"Sari I, Erkurt MA, Ifran A, Kaptan K, Beyan C. Multiple myeloma presenting with acquired factor VIII inhibitor. Int J Hematol. 2009;90:166\u20139.","journal-title":"Int J Hematol"},{"key":"3849_CR3","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1007\/s12185-021-03143-5","volume":"114","author":"S Inano","year":"2021","unstructured":"Inano S, Oku Y, Aiba A, Kawasaki N, Okamoto Y, Yuhi N, et al. Acquired hypofibrinogenemia in a patient with multiple myeloma. Int J Hematol. 2021;114:395\u2013400.","journal-title":"Int J Hematol"},{"key":"3849_CR4","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1007\/s00277-012-1600-5","volume":"92","author":"Y Hara","year":"2013","unstructured":"Hara Y, Makita M, Ishikawa T, Saeki K, Yamamoto K, Imajo K, et al. Lupus anticoagulant hypoprothrombinemia syndrome in Bence-Jones protein kappa-type multiple myeloma patient with phosphatidylserine-dependent antiprothrombin antibody. Ann Hematol. 2013;92:563\u20134.","journal-title":"Ann Hematol"},{"key":"3849_CR5","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1046\/j.1365-2141.1997.d01-2145.x","volume":"97","author":"NS Colwell","year":"1997","unstructured":"Colwell NS, Tollefsen DM, Blinder MA. Identification of a monoclonal thrombin inhibitor associated with multiple myeloma and a severe bleeding disorder. Br J Haematol. 1997;97:219\u201326.","journal-title":"Br J Haematol"},{"key":"3849_CR6","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1097\/00000441-199312000-00001","volume":"306","author":"F Robert","year":"1993","unstructured":"Robert F, Mignucci M, McCurdy SA, Maldonado N, Lee JY. Hemostatic abnormalities associated with monoclonal gammopathies. Am J Med Sci. 1993;306:359\u201366.","journal-title":"Am J Med Sci"},{"key":"3849_CR7","doi-asserted-by":"publisher","first-page":"e423","DOI":"10.3324\/haematol.2016.144873","volume":"101","author":"I Martinez-Martinez","year":"2016","unstructured":"Martinez-Martinez I, Gonzalez-Porras JR, Cebeira MJ, de Arriba F, Espin S, Bohdan N, et al. Identification of a new potential mechanism responsible for severe bleeding in myeloma: immunoglobulins bind the heparin binding domain of antithrombin activating this endogenous anticoagulant. Haematologica. 2016;101:e423\u20136.","journal-title":"Haematologica"},{"issue":"Suppl 77","key":"3849_CR8","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1111\/ejh.12500","volume":"94","author":"JJ Potgieter","year":"2015","unstructured":"Potgieter JJ, Damgaard M, Hillarp A. One-stage vs. chromogenic assays in haemophilia A. Eur J Haematol. 2015;94(Suppl 77):38\u201344.","journal-title":"Eur J Haematol"},{"key":"3849_CR9","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1111\/ijlh.13083","volume":"41","author":"A Suzuki","year":"2019","unstructured":"Suzuki A, Suzuki N, Kanematsu T, Shinohara S, Arai N, Kikuchi R, et al. Performance evaluation of Revohem\u2122 FVIII chromogenic and Revohem\u2122 FIX chromogenic in the CS-5100 autoanalyser. Int J Lab Hematol. 2019;41:664\u201370.","journal-title":"Int J Lab Hematol"},{"key":"3849_CR10","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1111\/j.1365-2125.2010.03899.x","volume":"72","author":"M Franchini","year":"2011","unstructured":"Franchini M, Mannucci PM. Inhibitors of propagation of coagulation (factors VIII, IX and XI): a review of current therapeutic practice. Br J Clin Pharmacol. 2011;72:553\u201362.","journal-title":"Br J Clin Pharmacol"},{"key":"3849_CR11","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1055\/s-0034-1390004","volume":"40","author":"A Tiede","year":"2014","unstructured":"Tiede A, Werwitzke S, Scharf RE. Laboratory diagnosis of acquired hemophilia A: limitations, consequences, and challenges. Semin Thromb Hemost. 2014;40:803\u201311.","journal-title":"Semin Thromb Hemost"},{"key":"3849_CR12","first-page":"612","volume":"34","author":"CK Kasper","year":"1975","unstructured":"Kasper CK, Aledort L, Aronson D, Counts R, Edson JR, van Eys J, et al. Proceedings: a more uniform measurement of factor VIII inhibitors. Thromb Diath Haemorrh. 1975;34:612.","journal-title":"Thromb Diath Haemorrh"},{"key":"3849_CR13","first-page":"990","volume":"57","author":"M Ieko","year":"2009","unstructured":"Ieko M, Naito S. Yoshida M [cross-mixing test to detect lupus anticoagulant for diagnosis of antiphospholipid syndrome]. Rinsho Byori. 2009;57:990\u20138.","journal-title":"Rinsho Byori"},{"key":"3849_CR14","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1182\/blood.V61.4.684.684","volume":"61","author":"SP Bajaj","year":"1983","unstructured":"Bajaj SP, Rapaport SI, Fierer DS, Herbst KD, Schwartz DB. A mechanism for the hypoprothrombinemia of the acquired hypoprothrombinemia-lupus anticoagulant syndrome. Blood. 1983;61:684\u201392.","journal-title":"Blood"},{"key":"3849_CR15","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1177\/0961203314558859","volume":"24","author":"SM Mulliez","year":"2015","unstructured":"Mulliez SM, De Keyser F, Verbist C, Vantilborgh A, Wijns W, Beukinga I, et al. Lupus anticoagulant-hypoprothrombinemia syndrome: report of two cases and review of the literature. Lupus. 2015;24:736\u201345.","journal-title":"Lupus"},{"key":"3849_CR16","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1097\/MD.0b013e31826b971f","volume":"91","author":"K Mazodier","year":"2012","unstructured":"Mazodier K, Arnaud L, Mathian A, Costedoat-Chalumeau N, Haroche J, Frances C, et al. Lupus anticoagulant-hypoprothrombinemia syndrome: report of 8 cases and review of the literature. Medicine (Baltimore). 2012;91:251\u201360.","journal-title":"Medicine (Baltimore)"},{"key":"3849_CR17","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1111\/j.1749-6632.1983.tb23232.x","volume":"408","author":"A Henschen","year":"1983","unstructured":"Henschen A, Lottspeich F, Kehl M, Southan C. Covalent structure of fibrinogen. Ann N Y Acad Sci. 1983;408:28\u201343.","journal-title":"Ann N Y Acad Sci"},{"key":"3849_CR18","doi-asserted-by":"publisher","first-page":"16862","DOI":"10.1074\/jbc.M113.464750","volume":"288","author":"TT Vu","year":"2013","unstructured":"Vu TT, Stafford AR, Leslie BA, Kim PY, Fredenburgh JC, Weitz JI. Batroxobin binds fibrin with higher affinity and promotes clot expansion to a greater extent than thrombin. J Biol Chem. 2013;288:16862\u201371.","journal-title":"J Biol Chem"},{"key":"3849_CR19","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1160\/TH14-04-0361","volume":"113","author":"RC Gosselin","year":"2015","unstructured":"Gosselin RC, Adcock D, Hawes EM, Francart SJ, Grant RP, Moll S. Evaluating the use of commercial drug-specific calibrators for determining PT and APTT reagent sensitivity to dabigatran and rivaroxaban. Thromb Haemost. 2015;113:77\u201384.","journal-title":"Thromb Haemost"},{"key":"3849_CR20","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.thromres.2015.05.001","volume":"136","author":"DM Adcock","year":"2015","unstructured":"Adcock DM, Gosselin R. Direct oral anticoagulants (DOACs) in the laboratory: 2015 review. Thromb Res. 2015;136:7\u201312.","journal-title":"Thromb Res"},{"key":"3849_CR21","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1111\/j.1365-2141.1991.tb04536.x","volume":"79","author":"W Nawarawong","year":"1991","unstructured":"Nawarawong W, Wyshock E, Meloni FJ, Weitz J, Schmaier AH. The rate of fibrinopeptide B release modulates the rate of clot formation: a study with an acquired inhibitor to fibrinopeptide B release. Br J Haematol. 1991;79:296\u2013301.","journal-title":"Br J Haematol"},{"key":"3849_CR22","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1111\/jth.13171","volume":"14","author":"TP Baglin","year":"2016","unstructured":"Baglin TP, Langdown J, Frasson R, Huntington JA. Discovery and characterization of an antibody directed against exosite I of thrombin. J Thromb Haemost. 2016;14:137\u201342.","journal-title":"J Thromb Haemost"},{"key":"3849_CR23","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1182\/blood.V35.5.695.695","volume":"35","author":"HA Perkins","year":"1970","unstructured":"Perkins HA, MacKenzie MR, Fudenberg HH. Hemostatic defects in dysproteinemias. Blood. 1970;35:695\u2013707.","journal-title":"Blood"},{"key":"3849_CR24","doi-asserted-by":"publisher","DOI":"10.1055\/a-2211-6841","author":"C Irsara","year":"2024","unstructured":"Irsara C, Griesmacher A, Loacker L, Feistritzer C, Uberbacher CA, Amiral J. Anti-Thrombin IgA in a Patient with Multiple Myeloma Leading to In Vitro Interference in Multiple Coagulation Tests and Confounding Diagnosis. Hamostaseologie. 2024. https:\/\/doi.org\/10.1055\/a-2211-6841.","journal-title":"Hamostaseologie"},{"key":"3849_CR25","doi-asserted-by":"publisher","first-page":"1669","DOI":"10.1080\/10428194.2022.2038376","volume":"63","author":"J Wang","year":"2022","unstructured":"Wang J, Arroyo-Suarez R, Dasari S, Sekaran K, Tse W. Early versus late response to daratumumab-based triplet therapies in patients with multiple myeloma: a pooled analysis of trials POLLUX, CASTOR and MAIA. Leuk Lymphoma. 2022;63:1669\u201377.","journal-title":"Leuk Lymphoma"}],"container-title":["International Journal of Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12185-024-03849-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12185-024-03849-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12185-024-03849-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,25]],"date-time":"2024-11-25T14:05:24Z","timestamp":1732543524000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12185-024-03849-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,18]]},"references-count":25,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2024,12]]}},"alternative-id":["3849"],"URL":"https:\/\/doi.org\/10.1007\/s12185-024-03849-2","relation":{},"ISSN":["0925-5710","1865-3774"],"issn-type":[{"value":"0925-5710","type":"print"},{"value":"1865-3774","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9,18]]},"assertion":[{"value":"31 January 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 September 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 September 2024","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 September 2024","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}